Biglycan gene connects metabolic dysfunction with brain disorder.

Area of Science:

• Neuroscience
• Metabolic Syndrome Research
• Extracellular Matrix Biology

Background:

• Dietary fructose contributes to obesity and diabetes, serving as a model for metabolic syndrome.
• The biglycan (Bgn) gene is implicated in the brain's response to fructose consumption.

Purpose of the Study:

• To investigate the role of biglycan (Bgn) in modulating fructose's effects on brain and body metabolism.
• To assess the impact of Bgn deficiency on learning, memory, and molecular pathways affected by fructose.

Main Methods:

• Exposure of male biglycan knockout mice (Bgn ^0/-) to fructose for seven weeks.
• Analysis of learning and memory performance, hippocampal CREB levels, and primary hippocampal neuronal cultures.
• Transcriptomic profiling of hypothalamus, hippocampus, and liver.

Main Results:

• Bgn ^0/- mice showed preserved learning and memory under fructose exposure, with attenuated effects on hippocampal CREB.
• Fructose reduced CREB and BDNF levels in neuronal cultures, an effect abolished by Bgn siRNA.
• Fructose-induced metabolic perturbations in glucose and lipids were altered in Bgn ^0/- mice.

Conclusions:

• Biglycan (Bgn) acts as a key modulator of fructose's impact on both brain function and systemic metabolism.
• The extracellular matrix component Bgn plays a tissue-specific role in regulating metabolism and neuronal plasticity.
• Targeting Bgn may offer therapeutic strategies for mitigating fructose-induced metabolic and cognitive dysfunction.